- Report
- December 2025
- 150 Pages
United States
From €4281EUR$4,850USD£3,697GBP
- Report
- December 2025
- 150 Pages
United States
From €4281EUR$4,850USD£3,697GBP
- Report
- December 2025
- 150 Pages
United States
From €4281EUR$4,850USD£3,697GBP
- Report
- October 2025
- 99 Pages
Middle East
From €4281EUR$4,850USD£3,697GBP
- Report
- June 2025
- 90 Pages
United States
From €4281EUR$4,850USD£3,697GBP
- Report
- July 2020
- 269 Pages
Global
From €3087EUR$3,497USD£2,666GBP
- Report
- October 2023
- 192 Pages
Global
From €4734EUR$5,551USD£3,950GBP
- Report
- September 2023
- 303 Pages
Global
From €4734EUR$5,551USD£3,950GBP
- Report
- June 2023
- 364 Pages
Global
From €4734EUR$5,551USD£3,950GBP
- Report
- August 2024
- 381 Pages
Global
From €4236EUR$4,799USD£3,658GBP
- Report
- March 2020
- 137 Pages
Global
From €4324EUR$4,899USD£3,734GBP
- Report
- November 2024
- 239 Pages
Global
From €3685EUR$4,175USD£3,182GBP
- Report
- January 2025
- 300 Pages
Global
From €4369EUR$4,950USD£3,773GBP
- Report
- December 2024
- 389 Pages
Global
From €4369EUR$4,950USD£3,773GBP
- Report
- November 2023
- 124 Pages
Global
From €3972EUR$4,500USD£3,430GBP
- Report
- April 2025
- 387 Pages
Global
From €3972EUR$4,500USD£3,430GBP
- Report
- August 2023
- 115 Pages
Global
From €1986EUR$2,250USD£1,715GBP
- Report
- January 2023
- 124 Pages
Global
From €1986EUR$2,250USD£1,715GBP
- Report
- January 2024
- 213 Pages
Global
From €4105EUR$4,650USD£3,545GBP
- Report
- December 2022
- 78 Pages
Global
From €4855EUR$5,500USD£4,192GBP

The Vaccine Development market is a subset of the Vaccines industry, which focuses on the research, development, and production of vaccines. Vaccines are biological preparations that provide active acquired immunity to a particular disease. Vaccine development involves the identification of antigens, the development of a vaccine formulation, and the production of the vaccine. Vaccine development is a complex process that requires significant resources and expertise.
The Vaccine Development market is highly competitive, with many companies competing to develop and produce vaccines. Companies in the market include Merck & Co., GlaxoSmithKline, Sanofi, Pfizer, Johnson & Johnson, and Novavax. Show Less Read more